Article info

Download PDFPDF

Multicenter Phase 2 Study of Combined Gemcitabine and Epirubicin as Second-Line Treatment for Patients With Advanced Ovarian Cancer

Authors

  1. Address correspondence and reprint requests to Viviana Murgia, MD, Department of Medical Oncology, Santa Chiara Hospital, Largo Medaglie d'Oro, 38100, Trento, Italy. E-mail: viviana.murgia{at}apss.tn.it.

Citation

Murgia V, Sorio R, Griso C, et al
Multicenter Phase 2 Study of Combined Gemcitabine and Epirubicin as Second-Line Treatment for Patients With Advanced Ovarian Cancer

Publication history

  • Received February 17, 2010
  • First published July 1, 2010.
Online issue publication 
July 01, 2010

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.